Related Experiment Video
Updated: Feb 4, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
Published on: October 27, 2014
A severe case of bevacizumab-induced thrombotic microangiopathy
Mert Bektas1, Nilay S Samancı2, Simay Cokgezer1
11 Department of Internal Medicine, Istanbul University Cerrahpaşa Medical Faculty Hospital, Istanbul, Turkey.
Abstract:
Bevacizumab is a human monoclonal antibody against VEGF. Many adverse reactions about bevacizumab are identified including venous and arterial thromboembolism, nausea, fatigue, alopecia, proteinuria, gastrointestinal system (GIS) perforation, exfoliative dermatitis, and peripheral edema and thrombocytopenia. In this paper, we report a case of bevacizumab-induced dose-dependent, toxicity-mediated drug-induced thrombotic microangiopathy.
Related Concept Videos
Induced-fit Model
Enzymes exhibit substrate specificity, meaning that they can only bind to certain substrates. This is mainly determined by the shape and chemical...
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Induced Electric Dipoles
Since the absolute value of potential energy holds no physical meaning, its zero value can be chosen as per...
Induced Electric Fields
Spontaneous and Induced Mutations

